GSROX
Price
$14.26
Change
+$0.17 (+1.21%)
Updated
Dec 20 closing price
VEXRX
Price
$114.79
Change
+$0.94 (+0.83%)
Updated
Dec 20 closing price
Ad is loading...

GSROX vs VEXRX

Header iconGSROX vs VEXRX Comparison
Open Charts GSROX vs VEXRXBanner chart's image
Goldman Sachs Small Cap Gr Insghts R
Price$14.26
Change+$0.17 (+1.21%)
VolumeN/A
CapitalizationN/A
Vanguard Explorer Adm
Price$114.79
Change+$0.94 (+0.83%)
VolumeN/A
CapitalizationN/A
GSROX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSROX vs. VEXRX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSROX is a Buy and VEXRX is a Buy.

FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 23.9B vs. GSROX (135M). VEXRX pays higher dividends than GSROX: VEXRX (0.58) vs GSROX (0.00). GSROX was incepted earlier than VEXRX: GSROX (17 years) vs VEXRX (23 years). GSROX is a more actively managed with annual turnover of: 153.00 vs. VEXRX (40.00). GSROX has a lower initial minimum investment than VEXRX: GSROX (0) vs VEXRX (50000). GSROX annual gain was more profitable for investors over the last year : 21.88 vs. VEXRX (12.06). VEXRX return over 5 years is better than : 17.83 vs. GSROX (-59.53).
GSROXVEXRXGSROX / VEXRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD21.77611.198194%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets135M23.9B1%
Annual Yield % from dividends0.000.58-
Returns for 1 year21.8812.06181%
Returns for 3 years8.36-1.32-631%
Returns for 5 years-59.5317.83-334%
Returns for 10 years-51.9132.40-160%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CODA8.230.36
+4.57%
Coda Octopus Group
ESPR2.190.02
+0.69%
Esperion Therapeutics
RRC33.180.04
+0.12%
Range Resources Corp
TFFP0.06N/A
N/A
TFF Pharmaceuticals
AGIO35.42-0.39
-1.09%
Agios Pharmaceuticals